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In the Lancet Infectious Diseases, Placide Mbala-Kingebeni and colleagues 2 demonstrated how in-country genomics capacity has been integrated in the current EVD outbreak response in North Kivu Province of the Democratic Republic of the Congo. The authors report the use of genomics tools for assessment of medical countermeasures such as diagnostics and therapeutics deployed during the outbreak. Mbala-Kingebeni and colleagues used real-time genomic viral sequencing to demonstrate that the virus strain identified in the North Kivu and Ituri Provinces is different from the strain identified in the previous May 2018 EVD outbreak in Équateur Province. The authors used the Nextera Flex method for viral genome enrichment, developed by Illumina Technologies (San Diego, CA, USA), to shorten the time between blood sample collection and generation of whole viral genome sequences from 72 to 28 h. They also identified a small number of mismatches and mutations in targeted areas of some PCR tests available for field deployment; however, none of these mismatches affected the performance of the PCR tests.
The authors' assessment of the binding capacity of the monoclonal antibodies Zmapp and mAb114-deployed as therapeutics during the previous outbreak-to the new strain of the Ebola virus identified in Ituri Province, showed that the changes in the newly identified Ituri strain did not affect their binding capacity. These findings were translated into actionable information and used by stakeholders for evidenced-based interventions in the outbreak response.
The approach used by these authors, 2 confirms and reinforces the notion that proactive, real-time genomic viral sequencing and surveillance of human populations represents a simple and cost-effective method of mitigating outbreaks in countries and locations that are most at risk of infectious disease outbreaks. For example, researchers at the African Center of Excellence for Genomics of Infectious Diseases (Redeemer's University, Ede, Nigeria) have used real-time nextgeneration sequencing technology to minimise public concerns regarding the surge in Lassa fever 5 and yellow fever 6 cases during the 2018 outbreaks in Nigeria, and successfully guided outbreak responses in the country.
To prepare for the next EVD outbreak, we advocate the establishment of national and regional hubs of excellence in infectious diseases genomics in regions with a high risk of outbreaks, where untargeted metagenomic sequencing analysis would be done. Thus, providing a potential one-step solution for outbreak pathogen detection of both known and novel pathogens would replace the need for multiple individual pathogen assays. 7 Although the main advantage of metagenomic sequencing is that it does not require a priori knowledge of the pathogen, specialised laboratory equipment and highly complex bioinformatic tools are required, which are expensive. Rapid identification of viruses will only be achieved if novel genomic technologies and the people trained to use them are available in many of the resource-limited regions of Africa where the risk of outbreaks is high.
The establishment of the African Center of Excellence for Genomics of Infectious Diseases as a regional hub of genomics excellence for infectious diseases by the National Institutes of Health (H3 Africa Consortium)
